KLARSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.19 EUR | -3.52% |
|
-22.48% | -19.49% |
| 03-15 | Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development | MT |
| 2023 | Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other IT Services & Consulting
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 7.82M | - | - | - | - | - | |
| 191B | ||||||
| 167B | ||||||
| 152B | ||||||
| 99B | ||||||
| 78.79B |
- Stock Market
- Equities
- ALKLA Stock
- Charts Klarsen
- Sector Chart
